What the US midterm elections mean for healthcare and pharma

The 2026 US midterm elections could shift healthcare and pharma policy depending on which party controls Congress. Democratic control would likely expand insurance coverage and increase drug-price negotiation efforts, while Republican control supports Medicaid restrictions and MFN pricing. Both parties favour more domestic pharma manufacturing citing national security concerns.

This Wire brief sits within Fusion42's coverage of Health.